Rexahn Pharmaceuticals Announces Publication of Preclinical Data for RX-3117 Demonstrating Effectiveness Against Gemcitabine Resistant Human Cancer Cells Jan 6, 2015
Rexahn Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 10, 2014 Dec 4, 2014
Rexahn Pharmaceuticals to Present at the Stifel 2014 Healthcare Conference on November 18, 2014 Nov 11, 2014
Rexahn Receives FDA Orphan Drug Designation for RX-3117 in Treatment of Pancreatic Cancer Sep 24, 2014
Rexahn Pharmaceuticals to Present at the 14th Annual Biotech in Europe Investor Forum for Global Partnering and Investment in Basel, Switzerland Sep 23, 2014